Trial Profile
Systolic and pulse pressure hemodynamic improvement by restoring elasticity: the SAPPHIRE study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2005
Price :
$35
*
At a glance
- Drugs Alagebrium chloride (Primary)
- Indications Isolated systolic hypertension
- Focus Therapeutic Use
- Acronyms SAPPHIRE
- 08 Oct 2005 New trial record.